Center for Drug Delivery and Nanomedicine, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States ...

After an initial meeting, the Working Group sent a draft document to 11 national and international pancreatic associations. This working draft was forwarded to all members. Revisions were made in ...

The proposed ABC system represents a simple and practical way to gauge the prognosis of patients with localized pancreatic cancer in whom neoadjuvant FOLFIRINOX is planned.* *Relevance section written ...

They replace the digestive enzymes your pancreas isn’t producing, helping your GI system process the nutrients in food. “The treatment works well for the majority of people,” says Regueiro.

The rescission process is a way for Congress to cancel funds it previously appropriated but that the federal government has not yet spent, rendering the funds no longer available to departments ...

SAN DIEGO — In treating pancreas divisum, the common use of endoscopic retrograde cholangiopancreatography (ERCP) with minor papilla endoscopic sphincterotomy showed no significant benefit over ...

Background Cyst size, its growth rate, and diameter of the main pancreatic duct (MPD) are all associated with pancreatic carcinoma prevalence in intraductal papillary mucinous neoplasms (IPMNs).

Again non homogenous lipomatosis is classified into four types; type 1a: head is usually replaced by fat, type 1b: head, neck and body are replaced by fat, type 2a: head and uncinate process replaced ...

Please provide your email address to receive an email when new articles are posted on . Rates of pancreatic adenocarcinoma increased significantly among younger individuals than older ones.

Cryptic peptides, which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, according to a new study. Researchers from MIT and ...

Cryptic peptides Pancreatic cancer has one of the lowest survival rates of any cancer—about 10% of patients survive for five years after their diagnosis. Most pancreatic cancer patients receive ...